Landscape of clinically actionable mutations in breast cancer ‘A cohort study’

Breast cancer (BC) is a heterogeneous disease. Numerous chemotherapeutic agents are available for early stage or advanced/metastatic breast cancer to provide maximum benefit with minimum side effects. However, the clinical outcome of patients with the same clinical and pathological characteristics a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Mithua, Naik, Radheshyam, Lingaraju, Sheela Mysore, Susheela, Sridhar Papaiah, Patil, Shekar, Srinivasachar, Gopinath Kodaganur, Thungappa, Satheesh Chiradoni, Murugan, Krithika, Jayappa, Srinivas Belagutty, Bhattacharjee, Somorat, Rao, Nalini, Bandimegal, Mahesh, Krishnappa, Roopesh, Poppareddy, Shashidhara Haragadde, Raghavendrachar, Krishna Chennagiri, Shivakumar, Yogesh, Nagesh, Sunitha, Kodandapani, Ramya, Rajan, Ashwini, Bahadur, Urvashi, Agrawal, Pooja, Ramaswamy, Veena, Nanjaiah, Tejaswini Bangalore, Kunigal, Sateesh, Katragadda, Shanmukh, Manjunath, Ashwini, Ram, Amritanshu, Ajaikumar, Basavalinga S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581976/
https://www.ncbi.nlm.nih.gov/pubmed/33099186
http://dx.doi.org/10.1016/j.tranon.2020.100877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581976/
https://www.ncbi.nlm.nih.gov/pubmed/33099186
http://dx.doi.org/10.1016/j.tranon.2020.100877

Ejemplares similares